These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16607252)

  • 21. Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
    McEwen A; West R
    BMC Public Health; 2009 Jan; 9():28. PubMed ID: 19159473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking cessation. Put your addiction in the ashtray for good.
    Mayo Clin Health Lett; 2002 Jun; 20(6):4-5. PubMed ID: 12066806
    [No Abstract]   [Full Text] [Related]  

  • 23. Smoking cessation.
    Marlow SP; Stoller JK
    Respir Care; 2003 Dec; 48(12):1238-54; discussion 1254-6. PubMed ID: 14651764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
    Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
    Johnson TS
    J Am Acad Nurse Pract; 2010 Oct; 22(10):557-63. PubMed ID: 21040090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking: can we really make a difference?
    Sutherland G
    Heart; 2003 May; 89 Suppl 2(Suppl 2):ii25-7; discussion ii35-7. PubMed ID: 12695432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic interventions for smoking cessation.
    Corelli RL; Hudmon KS
    Crit Care Nurs Clin North Am; 2006 Mar; 18(1):39-51, xii. PubMed ID: 16546007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A bupropion smoking cessation clinical trial for cancer patients.
    Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
    Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The truth about smoking cessation.
    Johns Hopkins Med Lett Health After 50; 2007 Oct; 19(8):3. PubMed ID: 18229416
    [No Abstract]   [Full Text] [Related]  

  • 30. [Smoking cessation and schizophrenia].
    Muller DP; de Haan L
    Tijdschr Psychiatr; 2017; 59(5):297-301. PubMed ID: 28593623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing on smoke free legislation making the most of the opportunity.
    Croghan E
    Br J Community Nurs; 2007 Aug; 12(8):334-6. PubMed ID: 17851296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bupropion: a new treatment for smokers. Nicotine replacement treatment should also be available on the NHS.
    Britton J; Jarvis MJ
    BMJ; 2000 Jul; 321(7253):65-6. PubMed ID: 10884238
    [No Abstract]   [Full Text] [Related]  

  • 33. Relapse prevention interventions for smoking cessation.
    Livingstone-Banks J; Norris E; Hartmann-Boyce J; West R; Jarvis M; Hajek P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003999. PubMed ID: 30758045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacotherapy of smoking cessation.
    Peters MJ; Morgan LC
    Med J Aust; 2002 May; 176(10):486-90. PubMed ID: 12065013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes from an outpatient smoking-cessation clinic.
    Roth MT; Andrus MR; Westman EC
    Pharmacotherapy; 2005 Feb; 25(2):279-88. PubMed ID: 15767242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking reduction interventions for smoking cessation.
    Lindson N; Klemperer E; Hong B; Ordóñez-Mena JM; Aveyard P
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013183. PubMed ID: 31565800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of weight concerns in a smoking abstinence clinical trial.
    Clark MM; Hurt RD; Croghan IT; Patten CA; Novotny P; Sloan JA; Dakhil SR; Croghan GA; Wos EJ; Rowland KM; Bernath A; Morton RF; Thomas SP; Tschetter LK; Garneau S; Stella PJ; Ebbert LP; Wender DB; Loprinzi CL
    Addict Behav; 2006 Jul; 31(7):1144-52. PubMed ID: 16137833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking habits and cessation programme in an Australian teaching hospital.
    Jones TE; Crocker H; Ruffin RE
    Aust N Z J Med; 1998 Aug; 28(4):446-52. PubMed ID: 9777112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking cessation pharmacotherapy preferences in rural primary care.
    Cupertino PA; Richter KP; Cox LS; Nazir N; Greiner AK; Ahluwalia JS; Ellerbeck EF
    Nicotine Tob Res; 2008 Feb; 10(2):301-7. PubMed ID: 18236294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.